Cadre Holdings, Inc. Financing Cash Flow
Cadre Holdings, Inc. (CDRE) reported Financing Cash Flow of $57.28 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05
- Cadre Holdings, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $4.39M, a 95.16% decline year-over-year.
- Cadre Holdings, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $52.89M.
- Cadre Holdings, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$43.77M, a 544.96% decline year-over-year.
- Cadre Holdings, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$7.59M.
- Cadre Holdings, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $31.59M, a 79.31% decline from fiscal 2024.
- Cadre Holdings, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $152.67M.
- Cadre Holdings, Inc. net cash provided by (used in) financing activities for fiscal 2023 was -$24.72M, a 201.06% decline from fiscal 2022.
- Cadre Holdings, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $24.46M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $57.28M 10-Q · filed 2026-08-05 | $13.52M derived: sum of 3 quarters · filed 2026-08-05 | $5.92M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $52.89M 10-Q · filed 2026-05-11 | $9.13M derived: sum of 2 quarters · filed 2026-05-11 | $1.53M derived: sum of 3 quarters · filed 2026-05-11 | $92.29M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$43.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$51.36M derived: sum of 2 quarters · filed 2026-03-10 | $39.40M derived: sum of 3 quarters · filed 2026-08-05 | $31.59M 10-K · filed 2026-03-10 |
| 2025-09-30 | -$7.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $83.16M derived: sum of 2 quarters · filed 2026-08-05 | $75.35M 10-Q · filed 2025-11-04 | $85.19M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $90.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $82.94M 10-Q · filed 2026-08-05 | $92.78M derived: sum of 3 quarters · filed 2026-08-05 | $85.73M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$7.81M 10-Q · filed 2026-05-11 | $2.02M derived: sum of 2 quarters · filed 2026-05-11 | -$5.03M derived: sum of 3 quarters · filed 2026-05-11 | $5.07M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $9.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.79M derived: sum of 2 quarters · filed 2026-03-10 | $12.88M derived: sum of 3 quarters · filed 2026-03-10 | $152.67M 10-K · filed 2026-03-10 |
| 2024-09-30 | -$7.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $3.04M derived: sum of 2 quarters · filed 2025-11-04 | $142.83M 10-Q · filed 2025-11-04 | $136.29M derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-06-30 | $10.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $149.88M 10-Q · filed 2025-08-05 | $143.34M derived: sum of 3 quarters · filed 2026-03-10 | $141.07M derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-03-31 | $139.79M 10-Q · filed 2025-05-06 | $133.25M derived: sum of 2 quarters · filed 2026-03-10 | $130.97M derived: sum of 3 quarters · filed 2026-03-10 | $124.37M derived: sum of 4 quarters · filed 2026-03-10 |
| 2023-12-31 | -$6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$8.81M derived: sum of 2 quarters · filed 2026-03-10 | -$15.42M derived: sum of 3 quarters · filed 2026-03-10 | -$24.72M 10-K · filed 2026-03-10 |
| 2023-09-30 | -$2.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$8.88M derived: sum of 2 quarters · filed 2024-11-06 | -$18.18M 10-Q · filed 2024-11-06 | -$24.93M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | -$6.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$15.91M 10-Q · filed 2024-08-09 | -$22.65M derived: sum of 3 quarters · filed 2025-03-11 | -$18.80M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | -$9.30M 10-Q · filed 2024-05-08 | -$16.05M derived: sum of 2 quarters · filed 2025-03-11 | -$12.20M derived: sum of 3 quarters · filed 2025-03-11 | $28.12M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | -$6.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$2.89M derived: sum of 2 quarters · filed 2025-03-11 | $37.42M derived: sum of 3 quarters · filed 2025-03-11 | $24.46M 10-K · filed 2025-03-11 |
| 2022-09-30 | $3.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $44.17M derived: sum of 2 quarters · filed 2023-11-08 | $31.21M 10-Q · filed 2023-11-08 | $40.97M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-06-30 | $40.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $27.36M 10-Q · filed 2023-08-08 | $37.12M derived: sum of 3 quarters · filed 2024-03-12 | $35.69M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-03-31 | -$12.96M 10-Q · filed 2023-05-09 | -$3.19M derived: sum of 2 quarters · filed 2024-03-12 | -$4.62M derived: sum of 3 quarters · filed 2024-03-12 | -$18.06M derived: sum of 4 quarters · filed 2024-03-12 |
| 2021-12-31 | $9.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $8.34M derived: sum of 2 quarters · filed 2024-03-12 | -$5.11M derived: sum of 3 quarters · filed 2024-03-12 | -$6.60M 10-K · filed 2024-03-12 |
| 2021-09-30 | -$1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$14.87M derived: sum of 2 quarters · filed 2022-11-10 | -$16.36M 10-Q · filed 2022-11-10 | -$38.96M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$13.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$14.93M 10-Q · filed 2022-08-11 | -$37.54M derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$1.49M 10-Q · filed 2022-05-16 | -$24.09M derived: sum of 2 quarters · filed 2022-05-16 | ||
| 2020-12-31 | -$22.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$64.90M 10-K · filed 2022-03-11 | ||
| 2020-09-30 | -$42.30M 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |